-
Jaguar Health CEO And Lead Ethnobotanical Researcher Explain The Decades Of Research That Made It A Leader In Plant-Based Drug Treatment
Wednesday, October 21, 2020 - 7:45am | 2110Read More...The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. With more than 30 years of ethnobotanical field research and ethnopharmacological compound analysis encompassing plant species and medical...
-
Jaguar Health CEO Discusses Upcoming Virtual Event Highlighting Long-Term Treatment Needs Of Cancer Patients
Thursday, October 15, 2020 - 7:29am | 1929Read More...The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Next Tuesday, October 20th, Jaguar Health, Inc. (NASDAQ: JAGX) will hold a live virtual webinar intended for investors that will bring...
-
'Psyched': Compass IPO, UC Berkeley's Psychedelics Center, Jaguar Health's Entheogen Initiative
Sunday, September 20, 2020 - 9:36am | 679Read More...Compass IPO Begins Trading on NASDAQ Following a NASDAQ filing earlier this month, UK-based psychedelics research company Compass Pathways began trading under the symbol CMPS on Friday. This is the first time a psychedelics company is listed on a major U.S. stock exchange. Some 7.5...
